Related Articles
Efficacy and safety of camrelizumab (a PD‑1 inhibitor) combined with chemotherapy as a neoadjuvant regimen in patients with locally advanced non‑small cell lung cancer
Survival of patients with pancreatic cancer treated with varied modalities: A single-centre study
Outcomes of stage II‑IV upper‑tract urothelial carcinoma and adjuvant chemotherapy for locally advanced cancer
Total neoadjuvant therapy in patients with locally advanced rectal cancer: A tertiary medical center experience
Expression of programmed death ligand-1 predicts poor outcome in nasopharyngeal carcinoma